has been examined in many studies since it was first utilized in schizophrenic patients. Here, we describe a patient with clozapine-resistant schizophrenia, whose psychosis and associated depression remitted significantly after switching treatment from clozapine to paliperidone. Case Report “Mr. Y, ” who was a 35-year-old man with a 10-year history of schizo-phrenia, was hospitalized because of frequent auditory hallucinations, persecutory delusions, and associ
Norio Yasui-Furukori, Kojiro Hashimoto, Kazutoshi Kubo, Tetsu Tomita Department of Neuropsychiatry, ...
Philip G Janicak1, Elizabeth A Winans2,31Department of Psychiatry, Rush University Medical Center, C...
Purpose of Review: This is a comprehensive review of the literature regarding the use of paliperidon...
significant depression symptoms and psychotic symptoms with significant exacerbations of self-care i...
schizophrenia is very difficult to treat because of the refractory characteristics toward the antips...
patients with dementia experi-enced more strokes and transient ischemic attacks than did placebo-tre...
This is a report on two cases of refractory schizophrenia and two cases of clozapine-resistant schiz...
is a movement disorder that can occur during antipsychotic medication use, occasionally after many m...
Objective : This study aimed to evaluate the clinical efficacy, safety, and tolerability of paliperi...
Carla M Canuso1, Ibrahim Turkoz2, Dong Jing Fu3, Cynthia A Bossie31External Innovation Neuroscience ...
Ryohei Takada, Kazuhiko Yamamuro, Toshifumi Kishimoto Department of Psychiatry, Nara Medical Univer...
Several clinical studies have shown a large number of mental symptoms by immunomodulatory treatment...
Objectives: The long-term safety, tolerability, and efficacy of paliperidone extended-release (ER) w...
Objective: This study was designed to explore the efficacy and tolerability of oral paliperidone ext...
AbstractBackgroundPatients with schizoaffective disorder (SCA) experience complicated interplays of ...
Norio Yasui-Furukori, Kojiro Hashimoto, Kazutoshi Kubo, Tetsu Tomita Department of Neuropsychiatry, ...
Philip G Janicak1, Elizabeth A Winans2,31Department of Psychiatry, Rush University Medical Center, C...
Purpose of Review: This is a comprehensive review of the literature regarding the use of paliperidon...
significant depression symptoms and psychotic symptoms with significant exacerbations of self-care i...
schizophrenia is very difficult to treat because of the refractory characteristics toward the antips...
patients with dementia experi-enced more strokes and transient ischemic attacks than did placebo-tre...
This is a report on two cases of refractory schizophrenia and two cases of clozapine-resistant schiz...
is a movement disorder that can occur during antipsychotic medication use, occasionally after many m...
Objective : This study aimed to evaluate the clinical efficacy, safety, and tolerability of paliperi...
Carla M Canuso1, Ibrahim Turkoz2, Dong Jing Fu3, Cynthia A Bossie31External Innovation Neuroscience ...
Ryohei Takada, Kazuhiko Yamamuro, Toshifumi Kishimoto Department of Psychiatry, Nara Medical Univer...
Several clinical studies have shown a large number of mental symptoms by immunomodulatory treatment...
Objectives: The long-term safety, tolerability, and efficacy of paliperidone extended-release (ER) w...
Objective: This study was designed to explore the efficacy and tolerability of oral paliperidone ext...
AbstractBackgroundPatients with schizoaffective disorder (SCA) experience complicated interplays of ...
Norio Yasui-Furukori, Kojiro Hashimoto, Kazutoshi Kubo, Tetsu Tomita Department of Neuropsychiatry, ...
Philip G Janicak1, Elizabeth A Winans2,31Department of Psychiatry, Rush University Medical Center, C...
Purpose of Review: This is a comprehensive review of the literature regarding the use of paliperidon...